Sunday, February 01, 2015 11:54:06 AM
Only those known to be exposed or potentially exposed would need the drug treatment, not the entire population.
"could possibly" is reality, given all the hypotheticals I brought up - "could possibly save more lives in the future (if the vaccine is safe enough, effective enough, if enough people take it, if the virus doesn't mutate enough, and if the virus is expected to be successful enough in the future to put a lot of people at risk)."
If a vaccine isn't safe, and it causes encephalitis or narcolepsy, or death, then that needs to be taken into account.
If a vaccine isn't very effective, it doesn't do as much good or save as many lives. The flu vaccine didn't save as many lives because it's not as effective this year.
If not enough people get vaccinated, then of course it doesn't do ANY good to the people not vaccinated.
If the virus mutates to something different enough from the vaccine, then the vaccine isn't very helpful then, either. What if someone is vaccinated for Ebola-Zaire, and the Ebola-Sudan virus circulates? What about this year the H3N2 flu mutated, making the vaccine less effective.
If the virus peters out or is not very prevalent in the population, and the chances of exposure to it are small, then of course, one wouldn't be helped by getting a vaccine against it. What are the odds that you or I will need a Ebola vaccine?
Anyways, always appreciate your discussion of the science, and good luck with your investments.
Recent NNVC News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:30:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 08:05:25 PM
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM